Companies / NAN

NANOSONICS LIMITED

ASX:NANHealth Care Equipment & Services
298.9M shares on issueASX (delayed) · as of 28 July 2026$2.99price · delayed$890.8Mmarket cap · indicative
A
Dilution grade

No major dilution pressure signals in current disclosures

Cash runwayno data — not a quarterly (4C/5B) cash filer
Share-count growth (24m)-1.3%
Raise cadence (24m)0 cash raises
Options & rights overhang2.2% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

NANOSONICS LIMITED's ordinary share count changed by -1.3% between June 2024 and June 2026, standing at 299M shares as of June 2026. There were no capital raises recorded in the 24-month window. Options and rights could convert into 7M new shares, equal to 2.2% of the current share count, with 0% in the money at the latest disclosure. The company does not have a current quarterly cash report on file, so no quarterly cash balance or funding-runway figure is disclosed on that basis. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
2.2%
Max option dilution
0.0%
ITM option dilution
0
Raises · last 12 months
Cash cover · not a quarterly filer

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 298.9M per ASX (delayed) (28 July 2026).
300.0M301.6M303.2MDec 24Sept 25July 26

Cash runway

Not a quarterly cash filer. This company does not lodge Appendix 4C/5B quarterly cash reports, so cash runway does not apply.

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
12 June 20263H · cancellationNAN : ORDINARY FULLY PAID298.7MAppendix 3H
9 June 20262A · quoted issueNAN : ORDINARY FULLY PAID298.9MAppendix 2A
29 Apr 20263H · cancellationNAN : ORDINARY FULLY PAID298.8MAppendix 3H
2 Apr 20263H · cancellationNAN : ORDINARY FULLY PAID303.4MAppendix 3H
2 Apr 20262A · quoted issueNAN : ORDINARY FULLY PAID303.4MAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

No equity raises in the last 24 months.
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

2.2%
Total overhang · of current shares
0.0%
In the money · at current price
6.7M
Potential new shares
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
25 Feb 2026Sarah ButlerBuy15k$51k3Y notice
18 Dec 2025Mr Michael KavanaghOther176k3Y notice
11 Dec 2025Mr Michael KavanaghOther59k3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.